We further investigated whether IL-21 is a key regulator of CRA-induced humoral immunity against the CRC tumor in vivo, by evaluating tumor growth inhibition by CRA following IL-21 neutralization (Fig. 6H). The gene discussed is IL21; the disease is colorectal carcinoma.